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ABSTRACT  It has previously been shown that the monoclonal antibody anti-Arc-1  dissociates 
Madin-Darby  canine  kidney  (MDCK) epithelial  cells  and  changes  their  morphology  in  vitro 
(Imhof, B. A.,  H. P. Vollmers, S. L. Goodman, and W.  Birchmeier,  1983, Cell, 35:667-675).  In 
this article we demonstrate that the anti-Arc-1  antibody recognizes an uvomorulin-like  mole- 
cule  on  MDCK  cells,  i.e.,  it  immunoprecipitates  an  84-kD  protein  fragment  from  a tryptic 
digest of cell surfaces  in the  presence of Ca  2+ (as does anti-uvomorulin  antiserum).  Further- 
more,  anti-uvomorulin  antiserum  prevents  the  binding  of  anti-Arc  1  to  MDCK  cells.  The 
distribution  of the Arc-1  antigen  is also quite  similar to that of uvomorulin:  it is enriched  at 
the cell-cell contacts both of MDCK cells and of cells in various canine tissues. In the intestinal 
epithelium  the antigen could be further localized in the region of the junctional complex. 
To  study  the  mechanism  of  action  of the  dissociating  antibody,  MDCK  cells  grown  on 
Nuclepore  filters  in  Boyden chambers were exposed  to anti-Arc-1  from  either the upper or 
lower compartment.  It could  be shown that the antibody  interfered  with cell adhesion  only 
from the basolateral  but not from the apical  cell surface.  Antibody action was inhibited  in the 
presence of colchicine  but not cytochalasin  B.  Furthermore, cell dissociation  was prevented 
when the cellular cAMP level  was raised. These findings indicate that the anti-Arc-1  antibody 
acts on a target below the tight junctions  (possibly on the antigen  located  in the junctional 
complex), and they confirm  that cytoskeleton  and  metabolic  factors  are actively  involved  in 
the maintenance of junctional  integrity. 
In recent years the process of cell adhesion  has been exten- 
sively studied.  In one line of research, antibodies that specif- 
ically inhibit cell-cell contacts have been used to identify the 
components involved (1-6). The neural  cell adhesion mole- 
cule (N-CAM) has been so identified,  and it seems to form 
direct bridges between neural cells (1, 7, 8). Different types of 
adhesion components have been discovered in nonneuronal 
cells (liver cell adhesion molecule [L-CAM]  1 in chickens [9]; 
Abbreviations used in this paper. Con A, concanavalin  A; L-CAM, 
liver cell adhesion molecule; MDCK, Madin-Darby canine kidney. 
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uvomorulin and cadherin in the mouse [2,  10,  11]; and cell 
adhesion molecule 120/80 in humans [12]).  Their biochemi- 
cal characteristics  and  their  distribution  in  different  tissues 
indicate that these adhesion components may all be closely 
related.  Thus,  L-CAM/uvomorulin-like adhesion  molecules 
are  found  on  cell  surfaces  and  have  molecular  weights  of 
-120,000,  from  which  84,000-mol-wt  fragments  can  be 
cleaved by trypsin in the presence of Ca  ~÷ (2,  13). They are 
enriched  at  cell  contact  areas  in  epithelial  tissues  (9),  and 
uvomorulin has been localized by immunoelectron  micros- 
copy at the intermediate junctions of  the intestinal epithelium 
1307 (14). Antibodies against this group of adhesion molecules can 
disturb cell-cell  adhesion  in tissue culture and also interfere 
with the compaction of mouse embryo blastocysts (2, 3). 
Our laboratory recently described the monoclonal antibody 
anti-Arc-l,  which  dissociates  Madin-Darby  canine  kidney 
(MDCK)  epithelial  cells  in  tissue  culture  (5).  Untreated 
MDCK cells are structurally and functionally polarized, i.e., 
they exhibit  strong intercellular junctions  and can transport 
ions vectorially. The anti-Arc-1  antibody seems to abolish this 
polarity:  the cells  loose their intimate  contacts,  they  reduce 
gap junctional communication, they become fibroblastic, and 
they  elaborate  microvilli  on  the  lateral  surfaces  (5).  In  this 
article we show that the Arc-1  antigen  is related to uvomo- 
rulin.  It  is  concentrated  at  the  junctional  complex  of the 
intestinal epithelium,  and the anti-Arc-1  antibody immuno- 
precipitates  an  84-kD  trypsin  fragment  from  MDCK  cells. 
We further show that the antibody functionally acts from the 
basolateral  but  not  the  apical  side  of the  cells  and  that  its 
action  is  modified  by drugs that alter cytoskeleton  and cell 
metabolism. 
MATERIALS  AND  METHODS 
Immunofluorescence of Cells and Frozen Sections:  MDCK 
cells were cultured to ~70% confluence on glass coverslips overnight (5), fixed 
with 3% formaldehyde in phosphate-buffered saline (pH 8.3) for  15 min, and 
permeabilized with 1% Triton X-100 for 5 min. They were then stained with 
70 #g/ml purified anti-Arc-I antibody (5), and appropriately diluted fluores- 
cein-labeled rabbit anti-mouse immunoglobulin (Miles-Yeda, Rehovot, Israel) 
was added.  All steps were carried out at room temperature. Specimens were 
mounted in Moviol 4-88 (Hoechst, Frankfurt) containing 1 mg/ml p-phenylen- 
diamine (to reduce fluorescence quenching) and examined on a Leitz Orthoplan 
photomicroscope. 
Cryostat sections were cut to thicknesses of 0.5  or 4-7  um  on a  Sorvall 
ultramicrotome MT-2B  (DuPont  Instruments-Sorvall Biomedical Div., Wil- 
mington,  DE) equipped with a  frozen thin sectioning system or a  Reichert- 
Jung Frigocut model 2700 (Jung,  Nussloch, FRG).  Sections were fixed with 
formaldehyde on gelatine-coated glass coverslips and prepared for immunoflu- 
orescence as described above. 
Immunoprecipitation and Binding Experiments:  MDCKcells 
were grown on  15-cm plates (Falcon Labware, Oxnard, CA) and labeled with 
[3~S]methionine as previously described (15).  The  cells were scraped off the 
plates into  1 ml  L-CAM  assay buffer (13) containing Ca++  and 0.2  mg/ml 
trypsin (type XI, Sigma Chemical Co., St.  Louis,  MO) and incubated for 40 
min at 37"C.  Egg-white trypsin inhibitor (0.8  rag, type II-O, Sigma Chemical 
Co.) was then added, and the cells were centrifuged for 5 min in an Eppendoff 
centrifuge. The supernatants were precleared four times on ice with 50 ul of a 
10%  suspension of Staphylococcus aureus, which had been presaturated with 
affinity-purified rabbit  anti-mouse  antibody.  Anti-Arc-I  antibody  (20  ug), 
control  IgGl  (20 ug anti-FC-l; see reference  16),  or rabbit anti-uvomorulin 
serum (20 #1) was then added, and after 3 h on ice the immune complexes were 
pelleted with 50 ~1 S.  aureus solution. For the precipitation of IgGl-antigen 
complexes, bacteria presaturated with rabbit anti-mouse immunoglobulin were 
used. The anti-uvomorulin serum was a generous gift of D. Vestweber and R. 
Kemler, Tiibingen (17). After they were extensively  washed with L-CAM assay 
buffer  containing 0.1%  Triton  X-100,  the  bacteria were  eluled with  SDS- 
dissociation buffer at 95°C, and the extracts were analyzed by SDS-gel electro- 
phoresis  and  autoradiography (15).  Alternatively the  trypsin  extracts were 
adsorbed on a 0.4 ml concanavalin A (Con A)-Sepharose column (Pharmacia 
Fine  Chemicals,  Uppsala,  Sweden)  and  eluted  with  200  mM  a-methyl-D- 
mannoside in L-CAM assay buffer. The eluants were then immunoprecipitated 
as described above. 
Binding  of  ~251-1abeled anti-Arc-I  antibody  to  fixed  and  permeabilized 
MDCK cells was performed as described (5, 16). For competition experiments, 
rabbit anti-uvomorulin antiserum or preimmune serum was added together 
with the radioactive antibody, and bound radioactivity was measured after 3 h. 
Boyden Chamber Experiments:  MDCKcelIs(5 x  104)  weregrown 
overnight on gelatine-coated Nuclepore filters (13-mm diam, 0.05-urn pore) in 
modified Boyden chambers (0.8-cm  well diam; Bio-Rad  Laboratories, Rich- 
mond, CA) until confluence was reached. Anti-Arc-I  antibody (70 ~,g/ml in 
complete culture medium) was then added  to either the upper or the lower 
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chamber. After 3 h of further culture, cells were fixed with 2.5% glutaraldehyde 
and inspected for cell dissociation by light and scanning electron microscopy 
(5).  For immunofluorescence, cells in the Boyden chamber were washed after 
short exposure to the anti-Arc-I antibody, fixed with 3%  formaldehyde, per- 
meabilized with  1%  Triton  X-100,  and  incubated  with  fluorescein-labeled 
rabbit anti-mouse immunoglobulin as described above. 
Drug Experiments:  Cells grown on glass coverslips to ~70% conflu- 
ence were incubated with medium containing 50 ug/mt anti-Arc-I antibody 
plus the various drugs at concentrations that alone did not markedly affect cell 
morphology: colchicine at 1 ug/ml; cytochalasin B at 0.05 #g/ml; 3-isobutyl l- 
methylxanthine (18) at 50 uM; forskolin (19) at 50 uM; and N602-dibutyryl 
cAMP at  10  mM  (all from  Sigma Chemical Co.);  A  23187  (20)  at  10  uM 
(Calbiochem-Behring Corp.,  San  Diego, CA); calmidazolium (21)  at  15  uM 
(Boehringer Mannheim, FRG); and cycloheximide at 10 ug/ml. Concentrated 
stock solutions of the drugs were prepared  in dimethyl sulfoxide except for 
colchicine and cycloheximide, which were in aqueous solution. Final concen- 
trations of dimethyl sulfoxide (which alone had no effect on cell morphology 
or on antibody action) did not exceed 0.25%. 
cAMP  concentration  was determined  with a  radioassay kit (Amersham 
International, Amersham, England) according to the manufacturer's procedure. 
MDCK cells (2 x  106) were lysed at 0*C in 0.1  M  HCI, and the supernatants 
were lyophilized and analyzed for cAMP. Basal levels of cAMP were 4-6 pmol/ 
mg cellular protein; forskolin increased this level by a  factor of 25,  isobutyl 
methylxanthine by a  thctor of 2.  Anti-Arc-I had no measurable effect on the 
cAMP level. 
Determination of Intercellular Communication:  MDCK ceils 
pretreated with various anti-Arc- 1 and drug combinations (as described in Drug 
Experiments) were microinjected with lissamine rhodamine RB 200 (100 mM, 
Polysciences Inc.,  Warrington,  PA) and incubated for  10  min  at  37"C.  For 
quantitation of cell coupling, 250 cells per experimental point were injected, 
and thc microscope image was captured on a silicon intensifying camera and 
displayed on a  TV  monitor (22). Cells were considered to be coupled when 
their outlines were clearly visible in the fluorescent image (5). 
RESULTS 
Immunolocalization of the Arc- 1 Antigen on 
MDCK Cells and Various  Tissue Sections 
To examine the location of the Arc-1 antigen, immunoflu- 
orescence  was performed  on cultured  MDCK  cells  and  on 
frozen sections of various canine tissues. No significant stain- 
ing was observed if fixed MDCK cells were not permeabilized. 
However,  detergent  extraction  resulted  in  a  characteristic 
staining, often in a punctuate pattern, along the lines of cell- 
cell contacts (Fig.  1, a and b). A control monoclonal antibody 
of the  same  isotype  showed  only background  staining.  The 
presence of the antigen at cell-cell contacts was confirmed by 
immunofluorescence  on frozen tissue  sections.  In the small 
intestine the antigen was restricted to the area of the junctional 
complex  (Fig.  1,  c  and  d).  Again,  no  such  staining  was 
observed with the control monoclonal antibody. In the canine 
kidney  cortex,  Arc-1  was  found  at  the  epithelial  cell-cell 
contacts of the distal tubules  but was virtually absent  from 
proximal tubules and glomeruli (Fig.  2,  a  and b).  We could 
also detect  the antigen  on sections  of the canine  epidermis 
(Fig. 2c).  Here the signal was confined to layers between the 
stratum corneum  and  the dermis.  In the hair follicle  Arc-1 
was also restricted to a defined cell layer (Fig. 2 d), the external 
root  sheath.  In  the  liver,  the  antigen  was  more  uniformly 
distributed  (Fig.  2 e), but again was enriched at the cell-cell 
borders. 
Relationship between anti-Arc-1  and the Cell- 
Adhesion Molecule Uvomorulin 
Since the distribution of the Arc-1 antigen on canine tissue 
revealed some similarity to uvomorulin of the mouse system 
(14), we compared the two molecules by immunoprecipitation FIGURE  1  Immunolocalization of the Arc-1  antigen on MDCK cells in tissue culture and on sections of the canine small intestine. 
(a) Immunofluorescence of fixed and  permeabilized MDCK  cells. (b) Corresponding phase-contrast image. (c)  Immunofluores- 
cence of the canine intestinal epithelium. (d) corresponding phase-contrast image. The section was 0.5 ~m thick, e, epithelial cell 
layer.  Ip,  lamina  propria, g,  goblet cell. A  control  antibody (anti-FC-1,  which  does not  react with  MDCK  cells;  reference  16) 
showed no staining at the cell borders. (a and b) x  600. (c and d) x  770. 
and in cell binding experiments. Uvomorulin can be specifi- 
cally cleaved from the cell surface by trypsin in the presence 
of Ca  2÷, yielding a characteristic 84-kD glycoprotein fragment 
(2).  Such  a  fragment  could  be  immunoprecipitated  from 
trypsin-treated MDCK cells by both anti-Arc-I  monoclonal 
antibody and a rabbit anti-uvomorulin serum (Fig.  3A). The 
84-kD trypsin fragment of uvomorulin is a  Con A-binding 
protein (2); we were also able to immunoprecipitate the 84- 
kD protein by the use of both antibodies from an eluant of a 
Con  A  column.  In  addition,  anti-uvomorulin  serum  com- 
peted  in  a  concentration-dependent  manner with  ~25I-anti- 
Arc-I binding to fixed and permeabilized MDCK cells (Fig. 
3B), whereas preimmune serum did not. These findings sug- 
gest that anti-Arc-1  recognizes an uvomorulin-like molecule 
in the canine epithelial cells. 
Anti-Arc- 1 Antibody Acts on the Basolateral  but 
Not the Apical Side of MDCK Cells 
The  localization  of the  Arc-1  antigen  at  the  junctional 
complex of the  intestinal  epithelium raised the question  of 
from which surface the dissociating antibody might reach the 
functional target. The anti-Arc-1 antibody was therefore pre- 
sented to either the upper or the lower surface of confluent 
MDCK monolayers growing on Nuclepore filters in Boyden 
chambers. Cell dissociation occurred only when the antibody 
was  delivered  to  the  basolateral  side  of the  cells  (Fig.  4, 
compare a with b). The average number of extended contacts 
of individual cells to their neighbors was 1.5 or 3.8, when the 
antibody was added to the lower or upper side,  respectively 
(40 cells counted in representative fields). Apparently the tight 
junctions prevented the access of  the antibody to its functional 
target when it was applied to the apical surface. This hypoth- 
esis was confirmed by immunofluorescence experiments using 
confluent, live MDCK cells in the Boyden chamber. The anti- 
Arc- 1 antibody bound to the cell contact areas of living cells 
only when it was presented from the lower chamber (Fig.  4, 
compare c with d). 
Modulation of Anti-Arc-1 Action by Drugs that 
Affect the Cytoskeleton and the cAMP System 
The anti-Arc-1 antibody dissociates MDCK cell monolay- 
ers and thus induces pronounced morphological changes in 
the  cells  (Fig.  5,  a  and  b;  the  average number of contacts 
between  individual  cells  and  their neighbors dropped from 
4.2 to  1.4; see also above). Cytoskeletal components or met- 
abolic events may contribute to these effects. To examine the 
involvement of the cytoskeleton, the influence of colchicine 
and  cytochalasins on  anti-Arc-1  activity was tested.  In  the 
presence of colchicine, disruption of the MDCK monolayer 
by anti-Arc-1  was inhibited (Fig.  5 c; the average number of 
cell  contacts  was  3.9).  Cytochalasin  B  did  not  inhibit  but 
rather slightly promoted antibody action (Fig. 5 d; the average 
number of contacts  was  1.1; cytochalasin D  had  a  similar 
effect). Apparently, an intact microtubular network is neces- 
sary for antibody activity whereas the microfilamentous net- 
work is less important. 
We also tested the effect of various drugs that influence cell 
metabolism.  Antibody  action  was  prevented when  cellular 
BEHRENS ET AL.  Dissociation of MDCK Epithelial Cells  1309 FIGURE  2  Immunolocalization of the Arc-1  antigen in sections of various canine tissues.  (a) Immunofluorescence of the kidney 
cortex.  (b) Corresponding phase-contrast picture, d, distal tubule, p,  proximal tubule. Glomeruli (not  in this section) were not 
stained. Section thickness, 2/Lm. x  350. (c) Immunofluorescence of the epidermis. I, dermis. II,  stratum germinativum. III,  stratum 
corneum. The arrowheads point to the surface of the epidermis, x  480.  (d)  Immunofluorescence of a  hair follicle. /, hair shaft 
and internal root sheath. II,  external root sheath. III,  dermal root sheath. The arrowhead indicates the border of the follicle, x  380. 
{e) Immunofluorescence of liver tissue. ×  500. Section thickness in c  e, 7/~m. 
cAMP was raised (Fig.  5,  e and f; contact numbers 3.5 and 
3.7). This was accomplished by the addition of isobutyl meth- 
ylxanthine (which inhibits cyclic nucleotide phosphodiester- 
ase  [18]),  or  forskolin  (which  activates  adenylate  cyclase 
[19];  see  also Materials and  Methods),  or dibutyryl cAMP. 
Compounds  that  affect  other  metabolic  processes  such  as 
cycloheximide,  calmidazolium  (an  inhibitor  of calmodulin 
action [21 ]), the Ca  2÷ ionophore A 23187 (20), and serum (0- 
20%)  did  not  interfere  with  the  antibody  effect (data  not 
shown). 
The anti-Arc-1 antibody also greatly reduces communica- 
tion of MDCK cells through gap junctions, as assessed in dye 
coupling experiments (5). Most MDCK cells are coupled, and 
antibody treatment decreases the amount of coupling (Fig. 6, 
compare a with b). As observed for the morphological effects 
of the  antibody,  colchicine  and  the  cAMP-elevating drug 
isobutyl methylxanthine counteract the uncoupling effects of 
the antibody (Fig. 6, c, e, and f), whereas cytochalasin B has 
no effect (Fig. 6 d). Under the conditions used, the drugs alone 
did not influence coupling. 
DISCUSSION 
In the  present study we present evidence that suggests  that 
the  Arc-I  antigen  of  MDCK  cells  is  an  uvomorulin-like 
molecule. First, the anti-Arc-1 monoclonal antibody precipi- 
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tares an 84-kD glycoprotein cleaved from the cell surface by 
trypsin  in  the  presence  of Ca  2÷.  This  cleavage  product  is 
characteristic of the L-CAM/uvomorulin family of adhesion 
proteins  (2,  13). Second,  anti-uvomorulin  antiserum  effi- 
ciently competes for the binding of anti-Arc- 1 to its target on 
fixed and permeabilized MDCK cells.  Third,  both antigens 
are localized at the borders of epithelial cells in culture and 
in certain tissues.  Last, Arc-1  and uvomorulin are restricted 
to the junctional complex of the intestinal epithelium. Taken 
together, these findings provide strong evidence for a  struc- 
tural and  functional homology between  Arc-1  and  uvomo- 
rulin. 
The intact epithelial cell adhesion molecules of the L-CAM/ 
uvomorulin  family are  120-kD proteins (3,  10,  13). In our 
earlier work (5) we identified Arc-1  as both  120- and 40-kD 
components by gel filtration of EDTA-cell extracts (uvomo- 
rulin can be extracted with EDTA from mouse teratocarci- 
noma cells [compare reference 10], although detergent extrac- 
tion  is  currently preferred). Thus,  the  120-kD Arc-I  might 
represent the  intact adhesion  molecule, whereas the  40-kD 
Arc-1  is probably a breakdown product. With the anti-Arc-1 
monoclonal antibody we have so far been unable to immu- 
noprecipitate the undigested 120-kD molecule from detergent 
extracts of MDCK cells.  However, the  120-kD uvomorulin 
could be readily identified in MDCK cells after immunopre- 
cipitation with anti-uvomorulin antiserum (not shown). FIGURE 3  Relationship  between the Arc-1 antigen and uvomorulin. (A) Immunoprecipitation of an 84-kD trypsin fragment. The 
fragment was prepared by digestion of [3SS]methionine-labeled MDCK cells in the presence of Ca  2÷ as described  in Materials and 
Methods. (Lanes b and f)  Immunoprecipitation using anti-Arc-1  antibody. (Lanes a and e) Controls  using a nonbinding IgG1 
monoclonal antibody. (Lanes d and h) Immunoprecipitation using anti-uvomorulin antiserum. (Lanes c and g) Controls with the 
preimmune serum. In lanes a-d precipitations were performed directly from the trypsin  extract.  In lanes e-h the trypsin  digest 
bound and eluted from a Con A-column with a-methyl-o-mannoside  was used for precipitation. The molecular weight markers 
are from the erythrocyte membrane. (B) Competition between the anti-Arc-1  antibody and anti-uvomorulin antiserum  for the 
binding to MDCK cells. Binding of 12Sl-labeled  anti-Arc-1  antibody to fixed and permeabilized MDCK cells (references 5 and 16) 
was tested in the presence of preimmune (lanes a and c) or anti-uvomorulin antiserum (a, b, 1:30 dilution; c, d, 1:10  dilution). 
The Arc-1  antigen could be detected in a variety of canine 
organs such as skin, intestine, kidney, and liver. Despite this 
relatively widespread occurrence, it is restricted to specialized 
cell types within single tissues.  For instance, it was detected 
on  distal,  but  less  on  proximal,  tubules  of the  kidney,  on 
external but not internal root sheath of the hair follicle,  and 
on distinct  layers of the epidermis.  The localization of the 
antigen in the distal kidney tubules correlates with the possible 
source of the MDCK cells  (23),  against which the antibody 
was raised. For L-CAM and uvomorulin, similar locations in 
certain epithelia have been reported. For instance, both pro- 
teins are enriched in the germinal layers of the epidermis and 
in the epithelia of the kidney tubules, but less in the epithelia 
of the glomeruli (9).  The reason for this restriction in only 
some  epithelia  is  not  at  present  clear.  It  might  reflect  a 
common property of the  various cell layers such as similar 
mechanical stability or similar state of differentiation. 
We have also shown here that the Arc- 1 antigen is enriched 
in the junctional complex of the intestinal epithelium (Fig.  1, 
c and d).  This agrees with the distribution of uvomorulin in 
the  intestine,  where  higher  resolution  analysis revealed yet 
further  restriction  to  the  intermediate junctions  (14).  We 
therefore could hypothesize that the anti-Arc-1 antibody pro- 
duces cell dissociation by first binding to a target in the area 
of the junctional complex, e.g., at the intermediate junctions, 
thereby  disturbing  critical  cell-cell  contacts.  Our  Boyden 
chamber experiments support this assumption, since the cell- 
dissociating anti-Arc- 1 antibody acts only from the basolateral 
and not from the apical side,  which indicates that  its func- 
tional target lies below the tight junctions. This also explains 
earlier  observations from  our  laboratory,  namely that  cell 
dissociation by anti-Arc- 1 was reduced when the MDCK cells 
grown on tissue culture plates were fully confluent; presum- 
ably the  antibody could  not  penetrate  the  monolayer and 
reach its target in this case. In our earlier article (5) we showed 
that the Arc-1  antigen could also be detected on the apical 
surface of MDCK cells by the extremely sensitive technique 
of immunoscanning electron  microscopy. The apical Arc-1 
may thus represent a subpopulation of the antigen below the 
detection  limit  of immunofluorescence,  or  may only exist 
before the  cells  become fully polarized.  Other investigators 
(24)  have  shown  that  polarization  of certain  antigens  in 
MDCK  cells  does  not  occur  until  full  confluence  of the 
monolayer is reached. 
The MDCK cell is an excellent in vitro system with which 
to study cell adhesion phenomena since it forms tight mono- 
layers, is well polarized, and expresses a series of characteristic 
cell-cell and cell-substrate junctions (5, 25, 26). The present 
work indicates that the uvomorulin-like Arc-1  antigen repre- 
sents a central adhesion component in the junctional complex 
of these cells,  i.e.,  the  disturbance  of one type of adhesion 
molecule  induces  complete dissociation  of the  monolayer. 
Anti-Arc- 1 destroys cell-cell contacts but also seems to abolish 
epithelial cell polarity, i.e.,  the cells move over one another 
and elaborate microvilli on their lateral surfaces (5). In effect, 
the cells are functionally deprived of Arc- 1, as they would be 
after a deletion of the Arc-l gene, or a down-regulation of the 
Arc-1  surface molecule. This suggests  that the expression of 
Arc-I  is necessary for a  correctly polarized monolayer and 
may alone be sufficient to  impose polarity on  the  MDCK 
cells. If this is a correct model, then differential activation of 
genes for Arc-l-like molecules could be a decisive controlling 
BEHRENS  ET  AL.  Dissociation  of MDCK Epithelial  Cells  1 31 1 FIGURE  4  Boyden chamber experiments. MDCK epithelial cells were grown to confluence on Nuclepore filters placed in Boyden 
chambers and exposed to the anti-Arc-1  antibody from either the lower or the upper compartment as described in Materials and 
Methods. The antibody dissociated the cells only when delivered to the basal (a),  not to the apical (b) side. x  1,200.  In c and d 
binding of the anti-Arc-1  antibody to living cells in the Boyden chamber is illustrated by immunofluorescence. After short-term 
incubation with anti-Arc-1  from the lower (c) or the upper (d) compartment, the cells were fixed and stained with fluorescently 
labeled second antibody. Bars, 10/~m. x  800. 
factor during organogenesis, when numerous mesenchymal- 
epithelial transitions occur. Recently, a monoclonal antibody 
against mouse uvomorulin (DECMA-1) was obtained which 
also dissociates MDCK cells (Vestweber, D., and R. Kemler, 
manuscript submitted for publication).  It will be interesting 
to find out whether this antibody also has free access to its 
target  only  from  the  basolateral  cell  surface,  and  whether 
other antibodies (e.g.,  anti-L-CAM) act in  the same fashion 
on polarized epithelial cells. 
How could  the  cytoskeleton- and  metabolism-perturbing 
drugs interplay with the cell-dissociating antibody? It is clear 
that the dissociation and shape change of MDCK cells  is a 
complex multistep process that shifts the cells from an epithe- 
lial  towards  a  fibroblastic  form  (Fig.  5,  a  and  b).  In  the 
epithelial state the MDCK cells are adhesive, communicative, 
and  polar.  In  contrast,  the  fibroblastic  cells  exhibit  little 
communication,  few  intercellular  junctions,  and  a  strong 
anterior-posterior polarity (25,  27).  We can hypothesize that 
any modulator that shifts the cells between these two extreme 
states might also affect the degree of anti-Arc-1  action.  For 
instance, it is known that cAMP can increase cell communi- 
cation in certain systems (28), and colchicine has been shown 
to destroy anterior-posterior polarity of fibroblasts (29). Thus, 
under the influence of both these erectors an epithelial form 
might be favored. By contrast, cytochalasin B itself  can induce 
spindle-shaped MDCK cells at higher concentration (e.g.,  at 
10 #g/ml) and might therefore potentiate anti-Arc-I action. 
After having considered  the  morphological changes during 
cell dissociation, we will  now look at what might happen at 
the  molecular level. The steric interference of the antibody 
with Arc-1  at or near cell contacts may lead to a  cascade of 
further events, e.g., a local influx of Ca  2÷ followed by closure 
of the gap junctions (5, 30). The cells, having now broken off 
communications with  their  neighbors  (Fig.  6),  might  then 
change  their  morphology,  a  change  requiring  cytoskeletal 
rearrangement, cAMP could counteract this since it keeps the 
gap junctions open (28) or might interfere with the cytoskel- 
eton  through  phosphorylation.  The  colchicine  experiments 
also point toward a critical role of the microtubules in these 
secondary processes. 
We should also consider that the anti-Arc- 1 antibody could 
actually trigger a change of differentiation of the MDCK cells 
from the epithelial to a fibroblastic (mesenchymal) stage. For 
instance,  when  Madin-Darby bovine kidney epithelial  cells 
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FIGURE 6  Effect  of the anti-Arc-1  antibody on coupling of MDCK 
cells:  modulation by  drugs  that  affect  cytoskeleton and  cAMP- 
metabolism.  MDCK monolayers were incubated for 1.5 h with the 
anti-Arc-1  antibody in  the presence  and  absence of the various 
drugs, which were used at the same concentrations as in  Fig. 5. 
Ceils were used (a) without antibody (control), or with (b) anti-Arc- 
1 antibody alone, (c) antibody plus colchicine, (d) antibody plus 
cytochalasin  B,  (e)  antibody plus  isobutyl methylxanthine, or (f) 
antibody plus  isobutyl methylxanthine and cytochalasin  B. After 
microinlection of  lissamine  rhodamine,  the  injected  cells  were 
grouped according to the number of neighboring cells that com- 
municated with them (see reference 5). 
are plated under conditions in which no intimate cell contacts 
are formed, they express a higher concentration of mesenchy- 
mal markers (31).  Furthermore, the drugs we have used are 
known  to  interfere with  such  differentiation processes: col- 
chicine and cytochalasin have opposite effects on chondrocyte 
differentiation (32),  and  cAMP partially restores the differ- 
entiated state of transformed chinese hamster ovary cells (33). 
It  has  recently been  shown  that  tumor  promoters produce 
morphological changes of MDCK cells similar to those of the 
anti-Arc-1 antibody (23, 34). However, these changes seem to 
be  different  from  the  ones  described in  the  present  study, 
since cAMP does not interfere with the effect of the tumor 
promoters (34), but cytocholasin B does. 
In conclusion, in this article we have further characterized 
the Arc-1  antigen as being localized at the cell borders (the 
junctional complex) of epithelial cells, and shown structural 
and  functional  homology of Arc-I  to  molecules of the  L- 
CAM/uvomorulin  family  of  adhesion  components.  How 
these molecules are involved in the adhesion of epithelial cells 
(e.g., whether homo- or heterotypic interaction is necessary), 
awaits further investigation. 
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